Evaluating a model for monitoring the virological efficacy of antiretroviral treatment in resource-limited settings

Lancet Infectious Diseases

Volumn 6, Issue 7, 2006, Pages 385-386

  Lawn, Stephen D ^a,b   Orrell, Catherine ^a   Wood, Robin ^a  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HEMOGLOBIN; PROTEINASE INHIBITOR; RIFAMPICIN;

BLOOD CELL COUNT; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFECT; HEALTH CARE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MONITORING; LABORATORY TEST; LETTER; LYMPHOCYTE COUNT; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURIGO; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TUBERCULOSIS; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; DEVELOPING COUNTRIES; HUMANS; MEDICALLY UNDERSERVED AREA; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; VIRAL LOAD;

EID: 33745218928     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(06)70498-4     Document Type: Letter

References (7)

1. WHO/UNAIDS. Progress of global access to HIV antiretroviral therapy. An update on "3 by 5" (June 2005). http://www.who.int/hiv/pub/progressreports/3by5%20Progress%20Report_E_light.pdf (accessed May 22, 2006)
2. Nkengasong J., Adje-Toure C., and Weidle P. HIV antiretroviral drug resistance in Africa. AIDS Rev 4 (2004) 4-12
3. Colebunders R., Moses K., Laurence J., et al. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. Lancet Infect Dis 6 (2006) 53-59
4. WHO. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach; 2003 revision. http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf (accessed May 30, 2006)
5. Lawn S., Myer L., Orrell C., Bekker L., and Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19 (2005) 2141-2148
6. Lawn S., Myer L., Bekker L., and Wood R. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis 6 (2006) 59
7. Bekker L., Myer L., Orrell C., Lawn S., and Wood R. Rapid scale up of a community-based HIV treatment programme: programme outcomes during three years of services in Gugulethu, South Africa. S Afr Med J 96 (2006) 315-320